Macrolide ºÒÀÀ¼º ¸¶ÀÌÄÚÇöóÁ Æó·Å°ú ÀûÇ÷±¸Æ÷½Ä¸²ÇÁÁ¶Á÷±¸Áõ: Áõ·Êº¸°í¿Í ¹®Çå°íÂû
Macrolide-refractory Mycoplasma pneumoniae pneumonia and hemophagocytic lymphohistiocytosis: case report and literature review
¸¶¼º¿¬, ±è´Üºñ, ÀÌÁÖ¿µ, Á¶°æ¼ø, ¼Áø¼ø, À̼ö¿µ,
¼Ò¼Ó »ó¼¼Á¤º¸
¸¶¼º¿¬ ( Ma Sung-Yun )
Catholic University College of Medicine Department of Pediatrics
±è´Üºñ ( Kim Dan-Bi )
Catholic University College of Medicine Department of Pediatrics
ÀÌÁÖ¿µ ( Lee Ju-Young )
Catholic University College of Medicine Department of Pediatrics
Á¶°æ¼ø ( Cho Kyoung-Soon )
Catholic University College of Medicine Department of Pediatrics
¼Áø¼ø ( Suh Jin-Soon )
Catholic University College of Medicine Department of Pediatrics
À̼ö¿µ ( Lee Soo-Young )
Catholic University College of Medicine Department of Pediatrics
Abstract
Mycoplasma pneumoniae causes various extra-pulmonary complications. As a rare but fatal hematological complication, hemophagocytic lymphohistiocytosis (HLH) can be observed in children with M. pneumoniae infection. We report a case of a 6-year-old girl with HLH who was initially presumed to have macrolide-refractory M. pneumoniae pneumonia. Despite the combination treatment of antimicrobial and anti-inflammatory agents, she showed persistent fever, hepatosplenomegaly, and thrombocytopenia. Secondary HLH associated with M. pneumoniae should be considered if unexplained clinical deterioration is noted in children with macrolide-refractory M. pneumoniae pneumonia.
Å°¿öµå
Child; Lymphohistiocytosis, Hemophagocytic; Macrolides; Mycoplasma pneumoniae; Treatment Failure
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸